<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01534117</url>
  </required_header>
  <id_info>
    <org_study_id>ASA/Plavix/Platelets_SBCH</org_study_id>
    <nct_id>NCT01534117</nct_id>
  </id_info>
  <brief_title>Platelet Function Analysis in Head Trauma: ASA/Plavix</brief_title>
  <acronym>ASA/Plavix</acronym>
  <official_title>Platelet Function Analysis in Head Trauma: ASA/CLOPIDOGREL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang, Steve S., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Santa Barbara Cottage Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Accumetrics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Chang, Steve S., M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are assessing the platelet function analysis of those who sustained
      significant head trauma while on aspirin or plavix and to assess if any qualitative
      difference is obtained if platelets are administered.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The platelet function analyzer VerifyNow® P2Y12 uses ADP as agonists to induce platelet
      activation and ascertain the level of platelet function impaired by these medications.
      VerifyNow® Aspirin Assay utilizes arachidonic acid as the agonist to measure platelet
      function specifically along this pathway. Our research question for this study is as follows:

      Does the administration of desmopressin (DDAVP) and/or the transfusion of platelets in
      patients with head trauma reverse the platelet inhibition caused by Aspirin and/or Plavix?
      The investigators hypothesize that with the administration of platelets and/or DDAVP that
      there is a reversal of the inhibition.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet inhibition</measure>
    <time_frame>8 hours</time_frame>
    <description>We are measuring platelet inhibition using the verify now platelet function analyzer</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">97</enrollment>
  <condition>Head Injury Trauma Blunt</condition>
  <arm_group>
    <arm_group_label>Platelets/DDAVP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fall on ASA/Plavix that sustained head trauma requiring administration of platelets and/or DDAVP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Platelets</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Those that sustain head trauma NOT requiring platelet transfusion. The investigators are evaluating platelet function in those not requiring platelet transfusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Platelets</intervention_name>
    <description>1 unit of platelets</description>
    <arm_group_label>Platelets/DDAVP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DDAVP</intervention_name>
    <description>Desmopressin 0.3mcg/kg IV x 1</description>
    <arm_group_label>Platelets/DDAVP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18yrs

          2. Must be a trauma patient with blunt head trauma.

          3. Must be on Aspirin and/or Plavix

          4. Subject or Legally Authorized Representative (LAR) (per Heath and Safety Code,
             Sections 24170 to 24179.5) must sign study consent within 4 hours from the first blood
             draw. (If this criterion is not met the initial blood draw must be destroyed and NOT
             run for study results).

        Exclusion Criteria:

          1. Hemoglobin ≤ 10 GM/DL

          2. Platelet Count ≤ 150 K/MCL

          3. Pregnant Females

          4. Subjects on Warfarin, Heparin or Enoxaparin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steve S Chang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santa Barbara Cottage Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Santa Barbara Cottage Hospital</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2012</study_first_submitted>
  <study_first_submitted_qc>February 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2012</study_first_posted>
  <last_update_submitted>February 15, 2012</last_update_submitted>
  <last_update_submitted_qc>February 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Craniocerebral Trauma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deamino Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

